PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 90 filers reported holding PLIANT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,754 | -4.3% | 3,100 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $56,172 | -31.9% | 3,100 | 0.0% | 0.00% | -40.0% |
| Q1 2023 | $82,460 | +37.6% | 3,100 | 0.0% | 0.01% | +25.0% |
| Q4 2022 | $59,923 | -6.4% | 3,100 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $64,000 | +178.3% | 3,100 | 0.0% | 0.00% | +300.0% |
| Q2 2022 | $23,000 | +9.5% | 3,100 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $21,000 | -48.8% | 3,100 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $41,000 | -22.6% | 3,100 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $53,000 | -39.1% | 3,100 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $87,000 | -15.5% | 3,100 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $103,000 | -15.6% | 3,100 | 0.0% | 0.00% | -40.0% |
| Q4 2020 | $122,000 | +281.2% | 3,100 | +106.7% | 0.01% | +150.0% |
| Q3 2020 | $32,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |